Hazards of (beta) blockadeBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1501b (Published 02 December 1995) Cite this as: BMJ 1995;311:1501
- Ton J M Cleophas,
- Robert B Kalmansohn
- Internist Department of Medicine, Merwede Hospital Dordrecht, PO Box 97, 3360 AB Sliedrecht, The Netherlands
- Professor of medicine and cardiology UCLA Medical Center, Los Angeles, CA, USA
Pressor effects may be important
EDITOR,--If doctors follow Morris J Brown's recommendation that “until current trials tell us otherwise … doctors can be encouraged to use either type of β blocker”1 then probably many more patients will be killed than the one described in the case report to which the final sentence of Brown's editorial (“One drop of timolol down the lacrimal duct can kill”) refers.
For more than 10 years non-selective …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial